In view of the well-established role of IL-15 and possible involvement of IL-2 in RA pathogenesis [19], [20], we attempted to test the feasibility of in vivo silencing of IL-2/15Rβ for the treatment of this disease. This evidence concerns the gene IL15 and rheumatoid arthritis.